Draft landscape of COVID-19 candidate vaccines

Overview

The COVID-19 candidate vaccine landscape database compiles detailed information on COVID-19 vaccine candidates in development.

The landscape is updated regularly – twice a week.

The landscape:

• Provides summary tables of COVID-19 vaccine candidates in both clinical and pre-clinical development;
• Provides analysis and visualization for several COVID-19 vaccine candidate categories;
• Tracks the progress of each vaccine from pre-clinical, Phase 1, Phase 2 through to Phase 3 efficacy studies,
• Provides links to published reports on safety, immunogenicity and efficacy data of the vaccine candidates;
• Includes information on the key attributes of each vaccine candidate;
• Allows users to search for COVID-19 vaccines through various criteria such as vaccine platform, dosage, schedule of vaccination, route of administration, developer, trial phase and clinical endpoints being measured in Phase 3.

These landscape documents have been prepared by the World Health Organization (WHO) for information purposes only concerning the 2019-2020 global of the novel coronavirus. Inclusion of any particular product or entity in any of these landscape documents does not constitute, and shall not be deemed or construed as, any approval or endorsement by WHO of such product or entity (or any of its businesses or activities). While WHO takes reasonable steps to verify the accuracy of the information presented in these landscape documents, WHO does not make any (and hereby disclaims all) representations and warranties regarding the accuracy, completeness, fitness for a particular purpose (including any of the aforementioned purposes), quality, safety, efficacy, merchantability and/or non-infringement of any information provided in these landscape documents and/or of any of the products referenced therein. WHO also disclaims any and all liability or responsibility whatsoever for any death, disability, injury, suffering, loss, damage or other prejudice of any kind that may arise from or in connection with the procurement, distribution or use of any product included in any of these landscape documents. 

Contact us

The R&D Blueprint team is responsible for developing the COVID-19 candidate vaccine landscape database. For questions relating to the collection or sharing of data for novel COVID-19 vaccine candidates, please contact us at: [email protected]